200,000+ products from a single source!

sales@angenechem.com

Home > Carboxes > 117414-74-1

117414-74-1

117414-74-1 | 2-Piperazinecarboxylic acid, 4-[(2E)-3-phosphono-2-propenyl]-, (2R)-

CAS No: 117414-74-1 Catalog No: AG000E9S MDL No:

Product Description

Catalog Number:
AG000E9S
Chemical Name:
2-Piperazinecarboxylic acid, 4-[(2E)-3-phosphono-2-propenyl]-, (2R)-
CAS Number:
117414-74-1
Molecular Formula:
C8H15N2O5P
Molecular Weight:
250.1889
IUPAC Name:
(2R)-4-[(E)-3-phosphonoprop-2-enyl]piperazine-2-carboxylic acid
InChI:
InChI=1S/C8H15N2O5P/c11-8(12)7-6-10(4-2-9-7)3-1-5-16(13,14)15/h1,5,7,9H,2-4,6H2,(H,11,12)(H2,13,14,15)/b5-1+/t7-/m1/s1
InChI Key:
VZXMZMJSGLFKQI-ABVWVHJUSA-N
SMILES:
OC(=O)[C@@H]1NCCN(C1)C/C=C/P(=O)(O)O
UNII:
7LYU6ZF84G

Properties

Complexity:
326  
Compound Is Canonicalized:
Yes
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
1  
Defined Bond Stereocenter Count:
1  
Exact Mass:
250.072g/mol
Formal Charge:
0
Heavy Atom Count:
16  
Hydrogen Bond Acceptor Count:
7  
Hydrogen Bond Donor Count:
4  
Isotope Atom Count:
0
Molecular Weight:
250.191g/mol
Monoisotopic Mass:
250.072g/mol
Rotatable Bond Count:
4  
Topological Polar Surface Area:
110A^2
Undefined Atom Stereocenter Count:
0
Undefined Bond Stereocenter Count:
0
XLogP3:
-7  

Literature

Title Journal
CCK-induced reduction of food intake and hindbrain MAPK signaling are mediated by NMDA receptor activation. Endocrinology 20120601
Reduction of food intake by cholecystokinin requires activation of hindbrain NMDA-type glutamate receptors. American journal of physiology. Regulatory, integrative and comparative physiology 20110801
An examination of NMDA receptor contribution to conditioned responding evoked by the conditional stimulus effects of nicotine. Psychopharmacology 20110101
NMDA NR2 receptors participate in CCK-induced reduction of food intake and hindbrain neuronal activation. Brain research 20090417
Blockade of hindbrain NMDA receptors containing NR2 subunits increases sucrose intake. American journal of physiology. Regulatory, integrative and comparative physiology 20090401
Orexin-A modulates glutamatergic NMDA-dependent spinal reflex potentiation via inhibition of NR2B subunit. American journal of physiology. Endocrinology and metabolism 20080701
Importance of screening logs in clinical trials for severe traumatic brain injury. Neurosurgery 20080601
Lowered brain stimulation reward thresholds in rats treated with a combination of caffeine and N-methyl-D-aspartate but not alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate or metabotropic glutamate receptor-5 receptor antagonists. Behavioural pharmacology 20060601
Effects of modulators of N-methyl-D-aspartate receptor-mediated neurotransmission on diazepam discrimination in rats. Life sciences 20040528
Synthesis and anticonvulsant activity of novel bicyclic acidic amino acids. Journal of medicinal chemistry 20030703
Inactivation of amino acid receptors in medullary reticular formation modulates and suppresses ingestion and rejection responses in the awake rat. American journal of physiology. Regulatory, integrative and comparative physiology 20030701
Involvement of glutamate receptors within the central nucleus of the amygdala in naloxone-precipitated morphine withdrawal-induced conditioned place aversion in rats. Japanese journal of pharmacology 20020401
The competitive NMDA receptor antagonist CPPene stimulates NREM sleep and eating in rats. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20020301
Effects of the NMDA receptor antagonist, D-CPPene, on sensitization to the operant decrement produced by naloxone in morphine-treated rats. Behavioural pharmacology 20010401
NMDA receptor antagonists do not block the development of sensitization of catalepsy, but make its expression state-dependent. Behavioural pharmacology 20010401
Thermal sterilization of heat-sensitive products using high-temperature short-time sterilization. Journal of pharmaceutical sciences 20010301
Evaluation of HIV-1 Tat induced neurotoxicity in rat cortical cell culture. Journal of neurovirology 20010201
N6-cyclohexyladenosine and 3-(2-carboxypiperazine-4-yl)-1-propenyl-1-phosphonic acid enhance the effect of antiepileptic drugs against induced seizures in mice. Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques 20010101
Effects of some excitatory amino acid antagonists on imipenem-induced seizures in DBA/2 mice. Brain research 19950206
[Effects of antagonists of NMDA receptor on methamphetamine-induced decrease in the dopamine uptake sites in the rat striatum and on the behavioral sensitization]. [Hokkaido igaku zasshi] The Hokkaido journal of medical science 19930501
Competitive and noncompetitive N-methyl-D-aspartate antagonists protect dopaminergic and serotonergic neurotoxicity produced by methamphetamine in various brain regions. Journal of neural transmission. General section 19930101

Related Products

© 2019 Angene International Limited. All rights Reserved.